Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 5/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.70 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.70 |
| ▸ | SERPINA6 | P08185 | 5/20 | 0.70 |
| ▸ | LMNA | P02545 | 3/20 | 0.70 |
| ▸ | MAPT | P10636 | 3/20 | 0.70 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.70 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.70 |
| ▸ | TSHR | P16473 | 2/20 | 0.70 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.70 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.70 |
| ▸ | PGR | P06401 | 2/20 | 0.70 |
| ▸ | AR | P10275 | 2/20 | 0.70 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.70 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.70 |
| ▸ | ABCB11 | O95342 | 2/20 | 0.70 |
| ▸ | SHBG | P04278 | 2/20 | 0.70 |
| ▸ | NR3C2 | P08235 | 2/20 | 0.70 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.70 |
| ▸ | MEN1 | O00255 | 1/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7884191 | 0.90 | CYP19A1 (0.61) | CYP3A4ALDH1A1SMN1; SMN2SERPINA6LMNA | |
| SCHEMBL7875309 | 0.89 | CYP19A1 (0.61) | CYP3A4ALDH1A1SMN1; SMN2SERPINA6LMNA | |
| SCHEMBL13981790 | 0.89 | CYP3A4 (0.67) | CYP3A4ALDH1A1SMN1; SMN2SERPINA6LMNA | |
| SCHEMBL1444719 | 0.89 | CYP3A4 (0.67) | CYP3A4ALDH1A1SMN1; SMN2SERPINA6LMNA | |
| SCHEMBL7875311 | 0.89 | CYP19A1 (0.61) | CYP3A4ALDH1A1SMN1; SMN2SERPINA6LMNA | |
| SCHEMBL367638 | 0.89 | CYP3A4 (0.67) | CYP3A4ALDH1A1SMN1; SMN2SERPINA6LMNA | |
| SCHEMBL2600423 | 0.84 | CYP3A4 (0.69) | CYP3A4SERPINA6LMNAMAPTMAPK1 | |
| SCHEMBL11754343 | 0.84 | CYP3A4 (0.69) | CYP3A4SERPINA6LMNAMAPTMAPK1 | |
| SCHEMBL11754338 | 0.84 | CYP3A4 (0.69) | CYP3A4SERPINA6LMNAMAPTMAPK1 | |
| SCHEMBL10926290 | 0.83 | ALDH1A1 (0.60) | CYP3A4ALDH1A1SMN1; SMN2SERPINA6LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117030904-B | Method for measuring 144 steroid hormones in environmental sample by liquid chromatography-mass spectrometry | 北京林业大学 | 2023-12-19 | — | — | CN | claimed |
| CN-117030904-A | Method for measuring 144 steroid hormones in environmental sample by liquid chromatography-mass spectrometry | 北京林业大学 | 2023-11-10 | — | — | CN | claimed |
| US-9572818-B2 | Pharmaceutical emulsion compositions comprising progestogen | BESINS HEALTHCARE LUXEMBOURG SARL (LU) | 2017-02-21 | — | — | US | disclosed |
| EP-2857042-B1 | Low-oil pharmaceutical emulsion compositions comprising progestogen | BESINS HEALTHCARE LU SARL (LU) | 2016-08-31 | — | — | EP | disclosed |
| CN-102946865-B | Comprise the pharmaceutical emulsion composition of the low oil of progestogen | 博赏医药卢森堡责任有限公司 | 2016-06-22 | — | — | CN | disclosed |
| EP-2801353-B1 | Pharmaceutical Emulsion Compositions Comprising Progestogen | BESINS HEALTHCARE LU SARL (LU) | 2016-03-30 | — | — | EP | disclosed |
| EP-2857042-A1 | Low-oil pharmaceutical emulsion compositions comprising progestogen | Besins Healthcare Luxembourg (LU) | 2015-04-08 | — | — | EP | disclosed |
| EP-2563335-B1 | LOW-OIL PHARMACEUTICAL EMULSION COMPOSITIONS COMPRISING PROGESTOGEN | BESINS HEALTHCARE LU SARL (LU) | 2014-12-17 | — | — | EP | disclosed |
| US-20140335133-A1 | LOW-OIL PHARMACEUTICAL EMULSION COMPOSITIONS COMPRISING PROGESTOGEN | BESINS HEALTHCARE LUXEMBOURG SARL (LU) | 2014-11-13 | — | — | US | disclosed |
| EP-2801353-A1 | Pharmaceutical Emulsion Compositions Comprising Progestogen | Besins Healthcare Luxembourg (LU) | 2014-11-12 | — | — | EP | disclosed |
| US-8765149-B2 | Low-oil pharmaceutical emulsion compositions comprising progestogen | BESINS HEALTHCARE LUXEMBOURG SARL (LU) | 2014-07-01 | — | — | US | disclosed |
| EP-2563334-A2 | PHARMACEUTICAL EMULSION COMPOSITIONS COMPRISING PROGESTOGEN | Besins Healthcare Luxembourg SARL (LU) | 2013-03-06 | — | — | EP | disclosed |
| CN-102946865-A | Low-oil pharmaceutical emulsion compositions comprising progestogen | BESINS HEALTHCARE LU SARL | 2013-02-27 | — | — | CN | disclosed |
| CN-102946864-A | Pharmaceutical emulsion compositions comprising progestogen | BESINS HEALTHCARE LU SARL | 2013-02-27 | — | — | CN | disclosed |
| WO-2011134937-A2 | PHARMACEUTICAL EMULSION COMPOSITIONS COMPRISING PROGESTOGEN | BESINS HEALTHCARE LUXEMBOURG SARL (LU) | 2011-11-03 | — | — | WO | disclosed |
| WO-2011134944-A2 | LOW-OIL PHARMACEUTICAL EMULSION COMPOSITIONS COMPRISING PROGESTOGEN | BESINS HEALTHCARE LUXEMBOURG SARL (LU) | 2011-11-03 | — | — | WO | disclosed |
| US-20110262494-A1 | LOW-OIL PHARMACEUTICAL EMULSION COMPOSITIONS COMPRISING PROGESTOGEN | BESINS HEALTHCARE LUXEMBOURG SARL | 2011-10-27 | — | — | US | disclosed |
| US-20110262495-A1 | PHARMACEUTICAL EMULSION COMPOSITIONS COMPRISING PROGESTOGEN | BESINS HEALTHCARE LUXEMBOURG SARL | 2011-10-27 | — | — | US | disclosed |
| US-4201778-A | 6-Acyloxy-1,4,6-pregnatrienes, their use as anti-inflammatory agents, methods for their manufacture, and 6-oxo-1,4-pregnadiene intermediates | SCHERING CORPORATION (US) | 1980-05-06 | — | — | US | disclosed |
| US-4201778-A | 6-Acyloxy-1,4,6-pregnatrienes, their use as anti-inflammatory agents, methods for their manufacture, and 6-oxo-1,4-pregnadiene intermediates | SCHERING CORPORATION (US) | 1980-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110262495-A1 | PHARMACEUTICAL EMULSION COMPOSITIONS COMPRISING PROGESTOGEN | PGR, CYP17A1, CYP19A1 | CYP3A4 287/4885ALDH1A1 4514/4885SMN1; SMN2 1331/4885 |
| US-20140335133-A1 | LOW-OIL PHARMACEUTICAL EMULSION COMPOSITIONS COMPRISING PROGESTOGEN | PGR, CYP17A1, PGRMC1 | CYP3A4 696/4885ALDH1A1 4653/4885SMN1; SMN2 1249/4885 |
| US-20110262494-A1 | LOW-OIL PHARMACEUTICAL EMULSION COMPOSITIONS COMPRISING PROGESTOGEN | PGR, CYP17A1, PGRMC1 | CYP3A4 696/4885ALDH1A1 4653/4885SMN1; SMN2 1249/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.